Correlation between decreased motor activity and dopaminergic degeneration in the ventrolateral putamen in monkeys receiving repeated MPTP administrations: A positron emission tomography study

作者: Yuji Nagai , Takafumi Minamimoto , Kiyoshi Ando , Shigeru Obayashi , Hiroshi Ito

DOI: 10.1016/J.NEURES.2012.02.007

关键词: MPTPDopaminergicDopamine transporterRacloprideNeuroscienceStriatumPrimary motor cortexPutamenDopaminePsychology

摘要: Parkinson's disease (PD) patients have remarkably reduced levels of dopaminergic biomarkers in the caudal putamen. However, relationship between motor impairments and localization intrastriatal degeneration monkey PD models remains unclear. To identify striatal areas with dysfunction responsible for impairments, we measured changes both general activity vivo three cynomolgus monkeys that repeatedly received 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), starting normal state continuing until after tremor appearance. Binding dopamine transporters (DAT) D(2) receptors were by positron emission tomography (PET) using [(11)C]PE2I [(11)C]raclopride, respectively. Region-of-interest-based regression analysis demonstrated degree reduction to be explained DAT binding but not receptor binding. Furthermore, voxel-based revealed a significant correlation decreased binding, specifically ventrolateral putamen, which corresponds area receiving upper body inputs from primary cortex. These results suggest specific functional deficits are closely related terminals subregion these functions level deficit is dependent on degeneration.

参考文章(30)
R Kurosaki, Y Muramatsu, H Watanabe, M Michimata, M Matsubara, Y Imai, T Araki, Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Metabolic Brain Disease. ,vol. 18, pp. 139- 146 ,(2003) , 10.1023/A:1023863003093
Kevin J Black, Jonathan M Koller, Abraham Z Snyder, Joel S Perlmutter, Atlas template images for nonhuman primate neuroimaging: baboon and macaque. Methods in Enzymology. ,vol. 385, pp. 91- 102 ,(2004) , 10.1016/S0076-6879(04)85006-7
K. J. Friston, C. D. Frith, P. F. Liddle, R. J. Dolan, A. A. Lammertsma, R. S. J. Frackowiak, The Relationship between Global and Local Changes in PET Scans Journal of Cerebral Blood Flow and Metabolism. ,vol. 10, pp. 458- 466 ,(1990) , 10.1038/JCBFM.1990.88
Y. Ma, V. Dhawan, M. Mentis, T. Chaly, P.G. Spetsieris, D. Eidelberg, Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study Synapse. ,vol. 45, pp. 125- 133 ,(2002) , 10.1002/SYN.10090
Alexxai V Kravitz, Benjamin S Freeze, Philip RL Parker, Kenneth Kay, Myo T Thwin, Karl Deisseroth, Anatol C Kreitzer, None, Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry Nature. ,vol. 466, pp. 622- 626 ,(2010) , 10.1038/NATURE09159
Aurelija Jucaite, Ikuo Odano, Hans Olsson, Stefan Pauli, Christer Halldin, Lars Farde, Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 33, pp. 657- 668 ,(2006) , 10.1007/S00259-005-0027-9
Chong S. Lee, Ali Samii, Vesna Sossi, Thomas J. Ruth, Michael Schulzer, James E. Holden, Jess Wudel, Pramod K. Pal, Raul De La Fuente-Fernandez, Donald B. Calne, A. Jon Stoessl, In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Annals of Neurology. ,vol. 47, pp. 493- 503 ,(2000) , 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
Yuji Nagai, Shigeru Obayashi, Kiyoshi Ando, Motoki Inaji, Jun Maeda, Takashi Okauchi, Hiroshi Ito, Tetsuya Suhara, Progressive changes of pre‐ and post‐synaptic dopaminergic biomarkers in conscious MPTP‐treated cynomolgus monkeys measured by positronemission tomography Synapse. ,vol. 61, pp. 809- 819 ,(2007) , 10.1002/SYN.20431